⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARMP News
Armata Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors
prnewswire.com
ARMP
PFE
Form 8-K
sec.gov
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
prnewswire.com
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update
prnewswire.com
ARMP
Pseudomonal Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
ARMP
GILD
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02
prnewswire.com
ARMP